Landec Corporation Working Capital

Working Capital of LNDC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Working Capital growth rates and interactive chart. Working capital, also known as net working capital (NWC), is the difference between a company’s current assets, such as cash, accounts receivable (customers’ unpaid bills) and inventories of raw materials and finished goods, and its current liabilities, such as accounts payable. Net operating working capital is a measure of a company's liquidity and refers to the difference between operating current assets and operating current liabilities. In many cases these calculations are the same and are derived from company cash plus accounts receivable plus inventories, less accounts payable and less accrued expenses. Working capital is a measure of a company's liquidity, operational efficiency and its short-term financial health. If a company has substantial positive working capital, then it should have the potential to invest and grow. If a company's current assets do not exceed its current liabilities, then it may have trouble growing or paying back creditors, or even go bankrupt.


Highlights and Quick Summary

  • Working Capital for the quarter ending February 27, 2021 was $37 Million (a -273.39% decrease compared to previous quarter)
  • Year-over-year quarterly Working Capital decreased by -607.87%
  • Annual Working Capital for 2020 was $-7.28 Million (a 79.78% increase from previous year)
  • Annual Working Capital for 2019 was $-4.05 Million (a -146.62% decrease from previous year)
  • Annual Working Capital for 2018 was $8.69 Million (a -70.87% decrease from previous year)
Visit stockrow.com/LNDC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Working Capital of Landec Corporation

Most recent Working Capitalof LNDC including historical data for past 10 years.

Interactive Chart of Working Capital of Landec Corporation

Landec Corporation Working Capital for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $36.98
2020 $-21.33 $-7.36 $-7.28 $-9.36 $-7.28
2019 $-4.18 $-16.27 $-4.05 $-4.61 $-4.05
2018 $-4.66 $1.49 $8.69 $23.26 $8.69
2017 $25.8 $30.71 $29.83 $39.4 $29.83
2016 $37.53 $34.34 $29.96 $37.55 $29.96
2015 $32.58 $38.03 $37.04 $36.65 $37.04
2014 $32.76 $35.88 $42.54 $42.86 $42.54
2013 $34.69 $33.56 $34.91 $33.71 $34.91
2012 $27.01 $16.57 $14.48 $50.13 $14.48
2011 $46.59 $47.73 $54.93 $51.35 $54.93
2010 $63.87 $63.64 $61.01 $61.01

Business Profile of Landec Corporation

Sector: Consumer Defensive
Industry: Packaged Foods
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets. It operates through Curation Foods and Lifecore segments. The Curation Foods segment engages in processing, marketing, and selling of vegetable-based salads, and fresh-cut and whole vegetable products primarily under the Eat Smart brand, O branded olive oils and wine vinegars, and Yucatan and Cabo Fresh guacamole and avocado food products, as well as various private labels. It serves retail grocery chains, club stores, and food service operators. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology transfer, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. It sells its products directly to partners in the medical device and pharmaceutical markets. The company was founded in 1986 and is headquartered in Santa Clara, California.